The exosomes derived from CAR-T cell efficiently target mesothelin and reduce triple-negative breast cancer growth
出版年份 2020 全文链接
标题
The exosomes derived from CAR-T cell efficiently target mesothelin and reduce triple-negative breast cancer growth
作者
关键词
CAR-T, Exosomes, Mesothelin, Triple-negative breast cancer, Tumor immunotherapy
出版物
CELLULAR IMMUNOLOGY
Volume 360, Issue -, Pages 104262
出版商
Elsevier BV
发表日期
2020-12-18
DOI
10.1016/j.cellimm.2020.104262
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Oncolytic adenovirus targeting TGF-β enhances anti-tumor responses of mesothelin-targeted chimeric antigen receptor T cell therapy against breast cancer
- (2020) Yuxiang Li et al. CELLULAR IMMUNOLOGY
- First-in-Human, Multicenter, Phase I Dose-Escalation and Expansion Study of Anti-Mesothelin Antibody–Drug Conjugate Anetumab Ravtansine in Advanced or Metastatic Solid Tumors
- (2020) Raffit Hassan et al. JOURNAL OF CLINICAL ONCOLOGY
- Genetic and pharmacological targeting of A2a receptor improves function of anti-mesothelin CAR T cells
- (2020) Elham Masoumi et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Combined antitumor effects of anti-EGFR variant III CAR-T cell therapy and PD-1 checkpoint blockade on glioblastoma in mouse model
- (2020) Yujie Song et al. CELLULAR IMMUNOLOGY
- CAR T Cells Targeting the Tumor MUC1 Glycoprotein Reduce Triple-Negative Breast Cancer Growth
- (2019) Ru Zhou et al. Frontiers in Immunology
- CTL-Derived Exosomes Enhance the Activation of CTLs Stimulated by Low-Affinity Peptides
- (2019) Shu-Wei Wu et al. Frontiers in Immunology
- CAR exosomes derived from effector CAR-T cells have potent antitumour effects and low toxicity
- (2019) Wenyan Fu et al. Nature Communications
- LincRNA-RoR/miR-145 promote invasion and metastasis in triple-negative breast cancer via targeting MUC1
- (2018) Jianli Ma et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Checkpoint inhibitors in triple-negative breast cancer (TNBC): Where to go from here
- (2018) Maryann J. Kwa et al. CANCER
- A novel AXL chimeric antigen receptor endows T cells with anti-tumor effects against triple negative breast cancers
- (2018) Jing Wei et al. CELLULAR IMMUNOLOGY
- Role of T cell-derived exosomes in immunoregulation
- (2018) Jian Lu et al. IMMUNOLOGIC RESEARCH
- CpG ODN1826 as a Promising Mucin1-Maltose-Binding Protein Vaccine Adjuvant Induced DC Maturation and Enhanced Antitumor Immunity
- (2018) Jing Jie et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Engineering Dendritic-Cell-Based Vaccines and PD-1 Blockade in Self-Assembled Peptide Nanofibrous Hydrogel to Amplify Antitumor T-Cell Immunity
- (2018) Pengxiang Yang et al. NANO LETTERS
- Chimeric Antigen Receptor Therapy
- (2018) Carl H. June et al. NEW ENGLAND JOURNAL OF MEDICINE
- CAR T cell immunotherapy for human cancer
- (2018) Carl H. June et al. SCIENCE
- Priming of dendritic cells by DNA-containing extracellular vesicles from activated T cells through antigen-driven contacts
- (2018) Daniel Torralba et al. Nature Communications
- Glutathione-induced amino-activatable micellar photosensitization platform for synergistic redox modulation and photodynamic therapy
- (2018) Ruiwei Guo et al. Biomaterials Science
- The hallmarks of successful anticancer immunotherapy
- (2018) Lorenzo Galluzzi et al. Science Translational Medicine
- Molecular alterations in triple-negative breast cancer—the road to new treatment strategies
- (2017) Carsten Denkert et al. LANCET
- Chimeric antigen receptor T-cell therapy — assessment and management of toxicities
- (2017) Sattva S. Neelapu et al. Nature Reviews Clinical Oncology
- Tragedy, Perseverance, and Chance — The Story of CAR-T Therapy
- (2017) Lisa Rosenbaum NEW ENGLAND JOURNAL OF MEDICINE
- Bioengineering Solutions for Manufacturing Challenges in CAR T Cells
- (2017) Nicole J. Piscopo et al. Biotechnology Journal
- Immunotherapy for breast cancer: past, present, and future
- (2016) Alison Spellman et al. CANCER AND METASTASIS REVIEWS
- Dendritic cell–derived exosomes for cancer therapy
- (2016) Jonathan M. Pitt et al. JOURNAL OF CLINICAL INVESTIGATION
- Immunotherapy in Breast Cancer- Paving New Roads?
- (2016) Cristina I. Truica et al. Current Molecular Pharmacology
- Mesothelin-Targeted CARs: Driving T Cells to Solid Tumors
- (2015) A. Morello et al. Cancer Discovery
- Therapeutic potential of CAR-T cell-derived exosomes: a cell-free modality for targeted cancer therapy
- (2015) Xiang-Jun Tang et al. Oncotarget
- Emerging Roles of Exosomes in Normal and Pathological Conditions: New Insights for Diagnosis and Therapeutic Applications
- (2015) Julieta De Toro et al. Frontiers in Immunology
- Efficacy of RG7787, a Next-Generation Mesothelin-Targeted Immunotoxin, against Triple-Negative Breast and Gastric Cancers
- (2014) C. Alewine et al. MOLECULAR CANCER THERAPEUTICS
- Mesothelin, a novel immunotherapy target for triple negative breast cancer
- (2012) Julia Tchou et al. BREAST CANCER RESEARCH AND TREATMENT
- Triple-Negative Breast Cancer
- (2010) William D. Foulkes et al. NEW ENGLAND JOURNAL OF MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now